Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
出版年份 2023 全文链接
标题
Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
作者
关键词
-
出版物
Annals of Thoracic Medicine
Volume 18, Issue 1, Pages 45
出版商
Medknow
发表日期
2023-01-25
DOI
10.4103/atm.atm_206_22
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
- (2021) Gabriela Leuschner et al. Frontiers in Medicine
- Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment
- (2020) Saba Noor et al. ADVANCES IN THERAPY
- Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis
- (2019) Timothy M. Dempsey et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Outcomes following decline in forced vital capacity in patients with idiopathic pulmonary fibrosis: Results from the INPULSIS and INPULSIS-ON trials of nintedanib
- (2019) Luca Richeldi et al. RESPIRATORY MEDICINE
- Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment
- (2019) Stefania Cerri et al. RESPIRATORY MEDICINE
- Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials
- (2018) Margaret Neighbors et al. Lancet Respiratory Medicine
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis
- (2018) Martin Kolb et al. NEW ENGLAND JOURNAL OF MEDICINE
- Focus on Idiopathic Pulmonary Fibrosis
- (2018) Fernando J. Martinez et al. CHEST
- South–West of England’s Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
- (2018) Shaney L. Barratt et al. Frontiers in Pharmacology
- Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years
- (2017) Ganesh Raghu EUROPEAN RESPIRATORY JOURNAL
- Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions
- (2017) Jonathan A. Galli et al. RESPIROLOGY
- Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
- (2017) Steven D Nathan et al. Lancet Respiratory Medicine
- Idiopathic pulmonary fibrosis
- (2017) Fernando J. Martinez et al. Nature Reviews Disease Primers
- First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value
- (2016) Wim A. Wuyts et al. LUNG
- Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
- (2015) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Treatment strategies for idiopathic interstitial pneumonias
- (2014) Athol U. Wells et al. CURRENT OPINION IN PULMONARY MEDICINE
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More